Custodial, Renograf, Hypothermosol, Perfadex. Based on Industry, Market is sub segmented into
Hypothermic Perfusion Preservation (HPP) and Static Cold Storage (SCS).
Regionally, The global market was dominated by Europe. This region is likely to be in the lead in the
coming few years due to technological advancement rapidly increasing in this region. The European
market for organ preservation solution is expected to progress at a steady rate during the forecast
period. Spain is contributing substantially to the European market.
Major Players profiled in the Organ Preservation Solutions Market report incorporate: Dr. Franz Köhler
Chemie, Teva Pharmaceutical Industries, Lifeline Scientific, Bristol-Myers Squibb, BioLife Solutions,
XVIVO Perfusion AB, ToleroTech, CryoLife, Claris Lifesciences Limited, BioTime, 21st Century Medicine
Latest Industry News
Bristol-Myers Squibb Company (NYSE:BMY) and Nitto Denko Corporation (Nitto) (6988:Tokyo) today
announced the companies have entered into an agreement granting Bristol-Myers Squibb exclusive
worldwide rights for the development and commercialization of Nitto’s investigational siRNA molecules
targeting heat shock protein 47 (HSP47) in vitamin A containing formulations, which includes Nitto’s
lead asset ND-L02-s0201, currently in Phase 1b study for the treatment of advanced liver fibrosis. The
agreement also grants Bristol-Myers Squibb the option to receive exclusive licenses for HSP47 siRNAs in
vitamin A containing formulations for the treatment of lung fibrosis and other organ fibrosis. The
agreement is subject to clearance under the Hart-Scott-Rodino Antitrust Improvements Act.
“Addressing the significant unmet need in fibrotic diseases is a key part of Bristol-Myers Squibb’s
strategy to build a sustainable and diversified portfolio of transformational medicines,” said Francis
Cuss, MB BChir, FRCP, executive vice president and chief scientific officer of Bristol-Myers Squibb. “We
continue to invest in innovative approaches both internally and externally that may halt or slow the
progression of fibrotic diseases and are pleased to partner with Nitto Denko to advance the
development of therapies for patients living with advanced NASH and cirrhosis due to NASH who
currently have limited treatment options.”
Request a Discount on standard prices of this premium report @
https://www.businessindustryreports.com/check-discount/164001 .
Region segment: This report is segmented into several key regions, with sales, revenue, market share
(%) and growth Rate (%) of Organ Preservation Solutions in these regions, from 2014 to 2023 (forecast),
covering: North America, Europe, Asia Pacific, Middle East & Africa and South America.
Significant points in table of contents: Market Definition, Market Overview, Business Introduction,
Segmentation (Region Level), Segmentation (Type Level), Segmentation (Industry Level), Segmentation
(Channel Level), Market Forecast Year, Segmentation Type, Segmentation Industry, Market Cost
Analysis, and Conclusion.
Report contents include